Publication:
Childhood onset myasthenia gravis

dc.contributor.authorNatte Raksadawanen_US
dc.contributor.authorKampanad Balankuraen_US
dc.contributor.authorTumtip Sangruchien_US
dc.contributor.authorPongkiat Kankirawatanaen_US
dc.contributor.authorPatcharin Prateepratanaen_US
dc.contributor.authorL. A Ongsri Atchaneeyasakulen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-24T03:07:15Z
dc.date.available2018-07-24T03:07:15Z
dc.date.issued2002-08-01en_US
dc.description.abstractThe authors share experiences in taking care of 27 cases of childhood onset myasthenia gravis (MGS). In all cases, the diagnosis was confirmed by a combination of clinical examination and Neostigmine test. The majority (92%) had localized ocular myasthenia with median onset of symptoms at 33 months of age. About 24 per cent of them progressed to generalized MGS. A few (8%) presented with respiratory failure that required ventilatory support with onset of symptoms at about 22 months. Thymectomy was performed in 10 cases. Complete and partial remissions were achieved in about 70 per cent and 26 per cent of cases respectively with the combination of an immunosuppressant (azathioprine) and a Cholinesterase inhibitor (pyridostigmine). None experienced a myasthenic crisis with proper management and good follow-up using the above combinations.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.85, No.SUPPL. 2 (2002)en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-0036702885en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/20440
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0036702885&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleChildhood onset myasthenia gravisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0036702885&origin=inwarden_US

Files

Collections